Peptide-based therapies for AMD are in the experimental stages, with several showing potential in preclinical and early clinical trials. However, more extensive research and clinical validation are necessary to confirm their safety and efficacy. It's advisable to consult with your healthcare providers before considering new treatments, as they can offer guidance based on the most current and comprehensive information.